Resultados de procura - David J. Lederer

Limitar resultados
  1. 1
    Selecting lung transplant candidates: where do current guidelines fall short?

    Selecting lung transplant candidates: where do current guidelines fall short? por J.L. Hook, David J. Lederer

    Publicado 2012
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Micromechanics of Alveolar Edema

    Micromechanics of Alveolar Edema por Carrie E. Perlman, David J. Lederer, Jahar Bhattacharya

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Screening High‐Resolution Computed Tomography of the Chest to Detect Interstitial Lung Disease in Systemic Sclerosis: A Global Survey of Rheumatologists

    Screening High‐Resolution Computed Tomography of the Chest to Detect Interstitial Lung Disease in Systemic Sclerosis: A Global Survey of Rheumatologists por Elana J. Bernstein, Dinesh Khanna, David J. Lederer

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Frailty in Pulmonary and Critical Care Medicine

    Frailty in Pulmonary and Critical Care Medicine por Jonathan P. Singer, David J. Lederer, Matthew R. Baldwin

    Publicado 2016
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey

    Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey por Gregory P. Cosgrove, Pauline Bianchi, Sherry Danese, David J. Lederer

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Delayed Access and Survival in Idiopathic Pulmonary Fibrosis

    Delayed Access and Survival in Idiopathic Pulmonary Fibrosis por Daniela Lamas, Steven M. Kawut, Emilia Bagiella, Nisha Philip, Selim M. Arcasoy, David J. Lederer

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary Fibrosis

    Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary Fibrosis por David J. Lederer, Selim M. Arcasoy, Jessie S. Wilt, F. D’Ovidio, Joshua Sonett, Steven M. Kawut

    Publicado 2006
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Hypoalbuminemia and Early Mortality After Lung Transplantation: A Cohort Study

    Hypoalbuminemia and Early Mortality After Lung Transplantation: A Cohort Study por Matthew R. Baldwin, Selim M. Arcasoy, Ashish S. Shah, P. Christian Schulze, Julia Sze, Joshua Sonett, David J. Lederer

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Vascular Inflammation in Obesity and Sleep Apnea

    Vascular Inflammation in Obesity and Sleep Apnea por Sanja Jelić, David J. Lederer, Tessa Adams, Margherita Padeletti, P.C. Colombo, Phillip Factor, Thierry H. Le Jemtel

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Sildenafil for Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial

    Sildenafil for Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial por David J. Lederer, Matthew N. Bartels, Neil W. Schluger, Frances Brogan, Patricia Jellen, Byron Thomashow, Steven M. Kawut

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Outcomes and Mortality Prediction Model of Critically Ill Adults With Acute Respiratory Failure and Interstitial Lung Disease

    Outcomes and Mortality Prediction Model of Critically Ill Adults With Acute Respiratory Failure and Interstitial Lung Disease por Whitney D. Gannon, David J. Lederer, Mauer Biscotti, Azka Javaid, Nina Patel, Daniel Brodie, Matthew Bacchetta, Matthew R. Baldwin

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Modeling of Fibrotic Lung Disease Using 3D Organoids Derived from Human Pluripotent Stem Cells

    Modeling of Fibrotic Lung Disease Using 3D Organoids Derived from Human Pluripotent Stem Cells por Alexandros Strikoudis, Anna Cieślak, Lucas F. Loffredo, Ya‐Wen Chen, Nina Patel, Anjali Saqi, David J. Lederer, Hans-Willem Snoeck

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation

    Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation por David M. Vock, Michael T. Durheim, Wayne Tsuang, Catherine Copeland, Anastasios A. Tsiatis, Marie Davidian, Megan L. Neely, David J. Lederer, Scott M. Palmer

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial

    Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial por Toby M. Maher, Tamera J. Corte, Aryeh Fischer, Michael Kreuter, David J. Lederer, María Molina‐Molina, Judit Axmann, Klaus-Uwe Kirchgaessler, Vincent Cottin

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis

    Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis por Michael Kreuter, David J. Lederer, María Molina‐Molina, Imre Noth, Claudia Valenzuela, Lutz Frankenstein, Derek Weycker, Mark Atwood, Klaus-Uwe Kirchgaessler, Vincent Cottin

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    A Prognostic Model for 6-Month Mortality in Elderly Survivors of Critical Illness

    A Prognostic Model for 6-Month Mortality in Elderly Survivors of Critical Illness por Matthew R. Baldwin, Wazim Narain, Hannah Wunsch, Neil W. Schluger, Joseph Cooke, Matthew J. Maurer, John W. Rowe, David J. Lederer, Peter B. Bach

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function

    Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function por Carlo Albera, Ulrich Costabel, Elizabeth A. Fagan, Marilyn K. Glassberg, Eduard Gorina, Lisa Lancaster, David J. Lederer, Steven D. Nathan, Dominique Spirig, Jeff Swigris

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Obesity and Underweight Are Associated with an Increased Risk of Death after Lung Transplantation

    Obesity and Underweight Are Associated with an Increased Risk of Death after Lung Transplantation por David J. Lederer, Jessie S. Wilt, F. D’Ovidio, Matthew Bacchetta, Lori Shah, Shankari Ravichandran, J. -L. J. Lenoir, Brenda Klein, Joshua Sonett, Selim M. Arcasoy

    Publicado 2009
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)

    Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and... por Toby M. Maher, Michael Kreuter, David J. Lederer, Kevin K. Brown, Wim Wuyts, Nadia Verbruggen, Simone Stutvoet, Ann Fieuw, Paul Ford, Walid Abi‐Saab, Marlies Wijsenbeek

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis

    Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis por Steven D. Nathan, Ulrich Costabel, Ian Glaspole, Marilyn K. Glassberg, Lisa Lancaster, David J. Lederer, Carlos A.C. Pereira, Benjamin Trzaskoma, Elizabeth Morgenthien, Susan L. Limb, Athol U. Wells

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: